Decoy Therapeutics is trading 13.45% up at $3.07 in after-hours trading, with no confirmed company-specific catalyst identified for the move.

  • It closed at $2.71 on September 15, 2026.
  • Shareholders approved warrant issuance and a reduction in authorized shares on September 14; those proposals were previously disclosed and do not clearly explain the rally.
  • The broader market was weaker, making the gain appear stock-specific but unexplained.